Adiponectin deficiency promotes diarrhea, stool hemoccult, and weight loss in DSS-induced colitis and contributes to inflammation-induced colon cancer [25–27], indicating that adiponectin treatment may play a beneficial role in colonic inflammation. This evidence concerns the gene ADIPOQ and malignant colon neoplasm.